| abstract |
The present invention provides a compound that inhibits the function of GIP, which is sufficiently satisfactory as a pharmaceutical, and further inhibits obesity, insulin resistance, or liver based on inhibition of GIP function, particularly inhibition of receptor binding of GIP. An agent for preventing or improving lipid accumulation is provided. A compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof, a GIP receptor binding inhibitor comprising the compound as an active ingredient, obesity prevention or the like An improver is provided. [In the formula, for example, W represents CR 1 (R 1 is a halogen atom or a cyano group) and the like, and V represents a nitrogen-containing heterocyclic ring. ] [Selection figure] None |